About this episode

The episode explores the relationship between GLP-1 medications and ADHD in women, focusing on the broader implications for health and neurodivergence.

Episode 213 with Katy Weber & Kalin Johnson In this first episode of our new series “Unmasking Our Health,” host Katy Weber teams up with cohost Kalin Johnson, PharmD, to explore a side of ADHD in women that isn’t talked about enough: What it’s like to live in a neurodivergent body. After years of interviewing late‑diagnosed women and seeing the same patterns — chronic pain, fatigue, autoimmune issues, hormonal chaos, gut problems, “mystery” symptoms — Katy created the Unmasking Our Health series to explore the bigger questions behind neurodivergence: What if ADHD isn’t just about our brains, but about our whole bodies — and how and why is the medical system missing the full picture? Our first topic for discussion: the explosion of GLP-1 medications (think Ozempic, Wegovy, Mounjaro) and what their surprising, wide-reaching effects are revealing about the deeply intertwined relationship between metabolic health, inflammation, hormones, and ADHD. In this episode, we cover: What is metabolic psychiatry? And why it's expanding how we understand ADHD beyond just dopamine and norepinephrine GLP-1 medications and ADHD — what patients are actually reporting (quieter brain, less…

People in this episode

Host: Katy Weber

Guest: Kalin Johnson

Topics covered

• ADHD
• women's health
• neurodivergence
• GLP-1 medications
• metabolic health
• chronic inflammation

Keywords

• ADHD
• GLP-1
• metabolic psychiatry
• chronic pain
• neuroinflammation
• hormonal chaos
• executive functioning

Mentioned in this episode

Products: Ozempic, Wegovy, Mounjaro

More episodes of Women & ADHD

• Caroline Maguire: Why do adult friendships feel so hard? · July 6, 2026 · 1h 4m
• Tory Berry & Chele Morony: DBT skills for neurodivergent brains · June 15, 2026 · 1h 3m

Explore listener stats, chart rankings, contacts and more on the Women & ADHD podcast page.